U.S. AstraZeneca vaccine trial will clear confusion on how well it works -U.S. scientist

By Julie Steenhuysen CHICAGO (Reuters) - A top U.S. scientist overseeing COVID-19 vaccine trials expects a large U.S. study to determine how effective AstraZeneca's experimental inoculation is, following perplexing results from other trials released by the company and partner Oxford University

Reuters December 08, 2020 06:05:43 IST
U.S. AstraZeneca vaccine trial will clear confusion on how well it works -U.S. scientist

US AstraZeneca vaccine trial will clear confusion on how well it works US scientist

By Julie Steenhuysen

CHICAGO (Reuters) - A top U.S. scientist overseeing COVID-19 vaccine trials expects a large U.S. study to determine how effective AstraZeneca's experimental inoculation is, following perplexing results from other trials released by the company and partner Oxford University.

AstraZeneca Plc is one of the leading vaccine developers, but interim data released Nov. 23 from trials in Britain and Brazil showed a vastly divergent performance when the vaccine was tested in two different dose combinations.

According to the company, a small group of trial subjects inadvertently received a half dose followed by a full dose, instead of the planned two full doses. In that group, the vaccine proved to be 90% effective at preventing illness. But the larger group that received two full doses showed a 62% success rate.

Although 62% efficacy is above the benchmark set by regulators to declare a COVID-19 vaccine a success, it pales when compared with efficacy of 95% and 94.1% demonstrated in large trials for vaccines from Pfizer Inc and Moderna Inc, respectively.

A U.S. study of AstraZeneca's vaccine involving about 30,000 volunteers is in the works and should produce data by late January.

"We feel very comfortable that we designed a really good trial in the United States, where everybody's getting boosted in a uniform time, and we know what the dose is," said Dr. Larry Corey, co-leader of the U.S. Coronavirus Vaccine Prevention Network, who helped design and is overseeing trials for the U.S. government Operation Warp Speed program.

The dosing in the British trial "wasn't done correctly," Corey maintains. Still, the dosing difference does not fully explain the variation in effectiveness seen in the U.K. and Brazilian trials, he said.

"One of the issues with the Oxford data is that there's a lot of lack of uniformity in the schedule and the dose that makes interpretation of the results difficult at best," he said in a phone interview.

There were also differences in the intervals between doses in the U.K. trial versus the Brazilian trial, as well as significant differences in the age range included in the studies. For example, everyone in the 90% effective group was under the age of 55, a group less susceptible to severe COVID-19.

"My personal summation is that there seems to be effectiveness in the AstraZeneca vaccine from this other trial that provides optimism that the current trial in the United States will define that effectiveness," said Corey, a virologist at Fred Hutchinson Cancer Research Center.

AstraZeneca did not respond immediately to a request for comment.

Moncef Slaoui, chief adviser for the Operation Warp Speed vaccine program, said last week the British and Brazilian trials may not be enough to ensure the vaccine receives a U.S. Food and Drug Administration emergency use authorization.

Results and potentially a request for U.S. emergency use authorization by AstraZeneca could come in late January, he said.

AstraZeneca has said it is considering a new global trial based on the half dose first regimen.

The U.S. trial calls for testing the original regimen of two full doses.

Should AstraZeneca decide to run a new U.S. trial testing the half dose first option, Corey said, the United States was unlikely to help foot the bill.

"Companies get to decide what they want to do," he said. "I'm sure they'll have to fund it themselves, or maybe somebody else would fund it for them."

(Reporting by Julie Steenhuysen; Additional reporting by Marisa Taylor in Washington; Editing by Bill Berkrot and Stephen Coates)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

France, Germany to agree to NATO role against Islamic State - sources
| Reuters
World

France, Germany to agree to NATO role against Islamic State - sources | Reuters

By Robin Emmott and John Irish | BRUSSELS/PARIS BRUSSELS/PARIS France and Germany will agree to a U.S. plan for NATO to take a bigger role in the fight against Islamic militants at a meeting with President Donald Trump on Thursday, but insist the move is purely symbolic, four senior European diplomats said.The decision to allow the North Atlantic Treaty Organization to join the coalition against Islamic State in Syria and Iraq follows weeks of pressure on the two allies, who are wary of NATO confronting Russia in Syria and of alienating Arab countries who see NATO as pushing a pro-Western agenda."NATO as an institution will join the coalition," said one senior diplomat involved in the discussions. "The question is whether this just a symbolic gesture to the United States

China's Xi says navy should become world class
| Reuters
World

China's Xi says navy should become world class | Reuters

BEIJING Chinese President Xi Jinping on Wednesday called for greater efforts to make the country's navy a world class one, strong in operations on, below and above the surface, as it steps up its ability to project power far from its shores.China's navy has taken an increasingly prominent role in recent months, with a rising star admiral taking command, its first aircraft carrier sailing around self-ruled Taiwan and a new aircraft carrier launched last month.With President Donald Trump promising a US shipbuilding spree and unnerving Beijing with his unpredictable approach on hot button issues including Taiwan and the South and East China Seas, China is pushing to narrow the gap with the U.S. Navy.Inspecting navy headquarters, Xi said the navy should "aim for the top ranks in the world", the Defence Ministry said in a statement about his visit."Building a strong and modern navy is an important mark of a top ranking global military," the ministry paraphrased Xi as saying.